Brothers’ little helper: why are investors losing faith in Pharmanovia?
Junked debt, management churn, botched accounting and family ties have spelt trouble for Basildon’s leading drugmaker
Junked debt, management churn, botched accounting and family ties have spelt trouble for Basildon’s leading drugmaker